bioProtonics' µTexture in vivo, MR-based diagnostic provides the resolving power needed to measure the ultra fine tissue changes that are the earliest harbingers of disease, thus enabling most effective application of therapeutics. µTexture is:Clinically robust—works in the "real world"Fits seamlessly into MRI radiology workflowOne minute added sequenceSoftware implementationno expensive hardware requiredReadily operable by any scan technician